HIV Infection in Children
Patricia Emmanuel, MD

This session will include an overview of the HIV pediatric epidemic and will provide a description of the evolution of HIV therapy, the benefits of early diagnosis and the success of perinatal HIV prevention. The presenter will discuss the challenges to the application of current approaches in developing countries.
(Handouts)

Pediatric HIV Research
Gwendolyn B. Scott, MD

The speaker will review the landmark studies on perinatal transmission and pediatric HIV therapy from which current management guidelines arise. Also, the speaker will evaluate the challenges of designing protocols for HIV therapeutic alternatives for pediatric patients. Learn about ongoing research studies on pediatric and adolescent HIV.
(Handouts)

HIV and Contraception
Diane Straub, MD, MPH

This session will cover an overview of the different contraceptive options available to youth and discuss the benefits and risks. Also, the speaker will discuss the available data on the pharmacologic interactions of contraceptives and antiretroviral therapy.
(Handouts)

New ARVs in their Role in Pediatric HIV
Ayesha Mirza, MD

This session will outline the goals of antiretroviral treatment in HIV-infected children and adolescents with a focus on the therapeutic options for salvage therapy on HAART- experienced patients. The speaker will discuss the role of new antiretroviral classes, such as integrase inhibitors, as well as CCR5 inhibitors. Participants will learn about options for simplification of current regimens or in the setting of toxicity.

(Handouts)

Immune Reconstitution Inflammatory Syndrome (IRIS)
George K. Siberry, MD, MPH

The speaker will describe the presentation of IRIS in HIV-infected children with understanding of the variety of infectious and inflammatory complications that constitute the syndrome. The speaker will also discuss diagnostic and therapeutic interventions used to minimize the occurrence and severity of this complication once HAART is initiated.
(Handouts)

Personal Resilience
Ana Garcia, PhD, LCSW

In this session, the speaker will define the concept of Personal Resilience in HIV perinatally-infected youth and discuss the main correlations associated between personal resilience and HIV health outcomes. Also, the speaker will summarize gaps in research regarding this new conceptual framework in HIV perinatally-infected youth.
(Handouts)

Life Skills Training for the Young Adult with Perinatally-Acquired HIV
Jenni Birkett Pfiffer, MSW, LCSW

In this session learn what service gaps/barriers are hampering the successful transitioning of HIV-infected youth to adult care. The speaker will outline the skills needed by HIV-infected youth to successfully transition to adult services. Also, learn to identify pertinent curricula that can be useful in the development of life-skills training modules.
(Handouts)

Decisional Capacity in HIV-infected Children and Adolescents
Tiffany Chenneville, PhD

The speaker will provide an assessment of the ability of HIV-infected children and adolescents to understand and participate in decisions regarding their own health. Factors, such as development, intellectual ability and social-emotional relationships that may impact HIV-infected children and adolescents’ opportunity to actively participate in health decision and adherence will also be outlined.
(Handouts)

Is an AIDS Defining Condition the End of the Road?
Delia María Rivera-Hernandez, MD

This session will compare the impact of early vs. late initiation of HAART in morbidity and mortality outcomes in pediatric HIV. The speaker will examine the differences in major clinical outcomes after initiation of HAART between HIV-infected children from developed countries vs. resource-limited countries. Also, the speaker will describe the effects of AIDS in immunological recovery.
(Handouts)

HIV Vaccine Research and New Immunizations
Carina A. Rodriguez, MD, FACCP

The development of an HIV vaccine remains a challenge to HIV investigators. The speaker will discuss an update on the results from recent trials and future initiatives toward an HIV vaccine. Also, the session will present a review of the current immunization schedule for HIV-infected and exposed infants. Finally, attendees will learn about new vaccines including the 13-valent pneumococcal vaccination, the H1N1 influenza vaccine and the HPV vaccines in males.
(Handouts pending approval)

Resistance
Zoe Rodriguez, MD

In this session, the speaker will review genotype, phenotype, integrase resistance and tropism assays, along with their indications and interpretation. Through interactive cases, major resistance profiles and appropriate therapeutic options will be reviewed.
(Handouts pending approval)

Sexual Activity and the Adolescent with HIV
Lawrence Friedman, MD

The speaker will examine the high-risk behaviors performed by adolescents infected with HIV and will describe the consequences of these behaviors from the legal, emotional, and reproductive standpoints. Learn which interventions are useful for the reduction of high-risk behaviors and for reproductive planning for HIV-infected adolescents.
(Handouts)

Approach to HIV in Correctional Facilities
JaDawn Wright, BA

This discussion will highlight the current challenges and approaches to HIV-infected patients in correctional facilities, as well as other high risk groups. The speaker will review strategies to address HIV disparities, alternative educational settings and community programs that assist with outreach efforts, HIV testing and linkage to care.
(Handouts)